Skip to main content
. 2022 Mar 15;4(1):85–94. doi: 10.1016/j.jaccao.2022.01.100

Table 2.

Site and Stage of Cancers

Stage
All 0 I II III IV ND
All 224,016 45,230 (20.2) 37,303 (16.7) 37,128 (16.6) 22,795 (10.2) 31,494 (14.1) 50,066 (22.4)
Gynecological 45,534 (20.3) 32,832 (72.1) 4,839 (10.6) 851 (1.9) 1,716 (3.8) 890 (2.0) 4,406 (9.7)
Genitourinary 43,296 (19.3) 3,560 (8.2) 5,997 (13.9) 17,483 (40.4) 3,841 (8.9) 4,237 (9.8) 8,178 (18.9)
Gastrointestinal 36,897 (16.5) 2,314 (6.3) 5,281 (14.3) 6,258 (17.0) 6,715 (18.2) 9,222 (25.0) 7,107 (19.3)
Breast 29,407 (13.1) 3,130 (10.6) 10,163 (34.6) 8,602 (29.3) 2,776 (9.4) 1,268 (4.3) 3,468 (11.8)
Thoracic 21,534 (9.6) 15 (0.1) 3,629 (16.9) 772 (3.6) 4,510 (20.9) 9,555 (44.4) 3,053 (14.2)
Hematological 19,558 (8.7) 0 (0.0) 1,617 (8.3) 1,447 (7.4) 1,312 (6.7) 3,094 (15.8) 12,088 (61.8)
 Leukemia 5,632 (2.5) 0 (0.0) 28 (0.5) 39 (0.7) 62 (1.1) 37 (0.7) 5,466 (97.1)
 Lymphoma 8,113 (3.6) 0 (0.0) 1,580 (19.5) 1,406 (17.3) 1,248 (15.4) 3,051 (37.6) 828 (10.2)
 Other 5,813 (2.6) 0 (0.0) 9 (0.2) 2 (0.0) 2 (0.0) 6 (0.1) 5,794 (99.7)
Melanoma 10,140 (4.5) 3,203 (31.6) 1,907 (18.8) 721 (7.1) 590 (5.8) 234 (2.3) 3,485 (34.4)
Head and neck 4,589 (2.1) 175 (3.8) 691 (15.1) 387 (8.4) 488 (10.6) 2,133 (46.5) 715 (15.6)
Nervous system 2,553 (1.1) 0 (0.0) 6 (0.2) 9 (0.4) 6 (0.2) 6 (0.2) 2,526 (98.9)
Other 10,508 (4.7) 1 (0.0) 3,173 (30.2) 598 (5.7) 841 (8.0) 855 (8.1) 5,040 (48.0)

Values are n (%). The all-stages column shows the percentage of each cancer site. The stage-specific columns show the percentage of each stage within each cancer site.

ND = not determined